Blue Ocean Barns Closes Funding Round for Production of Seaweed
Blue Ocean Barns announced the closure of a new $5 million seed round of capital, bringing the sustainable agriculture company’s total raised to date to $6.6 million. The funding round, led by Valor Siren Ventures, will support a significant expansion of Blue Ocean Barns’ farming operations as it readies for commercial sale of its seaweed-based cattle supplement. Blue Ocean Barns also signed a lease for 10 additional acres of growing space near its existing operations on the Big Island of Hawai’i.
LIVEKINDLY Collective Acquires Seaweed Burger Maker
LIVEKINDLY Collective, a collection of alternative protein brands, announced that it is acquiring Amsterdam-based company The Dutch Weed Burger. The Dutch Weed Burger makes a range of meat analogs using seaweed as the hero ingredient. Terms of the deal were not disclosed. Other startups using seaweed include New Wave Foods, which is making seaweed-based shrimp, and Oceanium which is using seaweed to make food protein, fiber and nutraceuticals, as well as home-compostable packaging materials.
Australian Firm Eyes Seaweed as Global Warming Game Changer
Those involved in an innovative project under way in Australia, say a genus of edible red algae called Asparagopsis drastically reduces emissions of methane, one of the major greenhouse gases, from ruminant livestock when used as a supplement in feed. “Inquiries have been pouring in from livestock farmers all over the world,” says Sam Elsom, CEO of Sea Forest, an environmental biotechnology company in Tasmania that is cultivating the seaweed.
Vivobarefoot Launches “Stop Harmful Algae Blooms” campaign
AU.K.-based footwear company has been making shoes out of algae blooms for the past five years. Now, they’re taking their passion for the issue to the public by calling for support on a petition that pushes UNESCO to encourage governments to take action on those poisoning the world’s waterways. Vivobarefoot gathered a host of voices, from scientists, doctors, and activists, to help share the Stop Harmful Algae Blooms campaign. So far over 10,000 signatures have been collected in an effort to elevate the conversation around algae blooms globally.
Lumen Bioscience and Novo Nordisk Enter into Research Pact
Lumen Bioscience is a clinical-stage biopharmaceutical company. It has entered into a research collaboration with Novo Nordisk to evaluate the use of Lumen’s unique drug development and manufacturing platform within obesity and other metabolic disorders. Lumen’s unique spirulina-based drug unlocks the potential for orally delivered biologic drugs by manufacturing them with the scalability and affordability more typical of small-molecule drugs.
All rights reserved. Permission required to reprint articles in their entirety. Must include copyright statement and live hyperlinks. Contact firstname.lastname@example.org. Algae Planet accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.